The analysis showed that HMGB1 levels from BAL performed on central airways did not significantly differ among the three groups; instead those levels from BAL obtained from peripheral airways were significantly higher in COPD patients than in nonsmokers or smokers without COPD. Here, HMGB1 is linked to chronic obstructive pulmonary disease.